首页> 外国专利> Dab2 Composition for prevention or treatment of autoimmune disease comprising Dab2-overexpressing dendritic cells

Dab2 Composition for prevention or treatment of autoimmune disease comprising Dab2-overexpressing dendritic cells

机译:用于预防或治疗自身免疫性疾病的Dab2组合物,其包含过表达Dab2的树突状细胞

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of autoimmune diseases, and more particularly to a pharmaceutical composition for preventing or treating autoimmune diseases comprising semi-mature dendritic cells overexpressing the Dab2 gene.The composition according to the present invention is characterized in that the semi-mature dendritic cells having Dab2 gene overexpression or Dab2 protein activity as an active ingredient and the Dab2 gene overexpressing or Dab2 protein having increased activity are antigen-specific Inhibiting T cell proliferation, inhibiting the expression of inflammatory cytokines, and increasing the ratio of anti-inflammatory cytokine expression and regulatory T cells, thereby preventing, ameliorating or treating autoimmune diseases including arthritis It is expected that it can be usefully used as a pharmaceutical composition for
机译:本发明涉及用于预防或治疗自身免疫疾病的药物组合物,更具体地,涉及用于预防或治疗包含过量表达Dab2基因的半成熟树突状细胞的自身免疫疾病的药物组合物。因为具有Dab2基因过表达或Dab2蛋白活性作为活性成分的半成熟树突状细胞和具有Dab2基因过表达或Dab2蛋白具有增强的活性的半成熟树突细胞是抗原特异性的抑制T细胞增殖,抑制炎性细胞因子的表达并增加了炎性细胞因子表达与调节性T细胞的比例,从而预防,改善或治疗包括关节炎在内的自身免疫性疾病有望将其有效地用作药物组合物

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号